Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001161697-25-000075
Filing Date
2025-02-26
Accepted
2025-02-26 17:00:18
Documents
1
Period of Report
2025-02-13

Document Format Files

Seq Description Document Type Size
1 FORM 3 FOR 02-13-2025 form_3.html 3  
1 FORM 3 FOR 02-13-2025 form_3.xml 3 6880
  Complete submission text file 0001161697-25-000075.txt   8584
Mailing Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICALS, INC. (Issuer) CIK: 0001369568 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134
Business Address
Russo Gregg (Reporting) CIK: 0002058326 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33057 | Film No.: 25671135